Doctor’s Guide -- BOSTON -- October 4, 2010 -- Researchers have conducted a study that failed to show a difference in efficacy between bevacizumab (Avastin) and ranibizumab (Lucentis) for the treatment of age-related macular degeneration (AMD).
Doctor’s Guide -- BOSTON -- October 4, 2010 -- Researchers have conducted a study that failed to show a difference in efficacy between bevacizumab (Avastin) and ranibizumab (Lucentis) for the treatment of age-related macular degeneration (AMD).